The French polidocanol study on long-term side effects: A survey covering 3,357 patient years

Dermatologic Surgery

Volumn 36, Issue SUPPL. 2, 2010, Pages 993-1003

  Guex, Jean Jerome ^a   Schliephake, Dorothee E ^b   Otto, Joachim ^b   Mako, Serge ^c   Allaert, Francois Andre ^d  

^a Cabinet de Phlebologie   (France)

^b Chemische Fabrik Kreussler and Co GmbH   (Germany)

^c Laboratoire Kreussler Pharma France   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; GLYCEROL; POLIDOCANOL; TETRADECYL SULFATE SODIUM;

ALLERGIC REACTION; ANTICOAGULANT THERAPY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FOAM SCLEROTHERAPY; FOLLOW UP; FRANCE; HETEROZYGOTE; HUMAN; INCIDENCE; INFLAMMATION; LIQUID SCLEROTHERAPY; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; NAUSEA; PARESTHESIA; PHLEBITIS; PIGMENT DISORDER; PRIORITY JOURNAL; REGISTER; REVIEW; SCLEROTHERAPY; SYNCOPE; THROMBOPHLEBITIS; VARICOSIS; VEIN THROMBOSIS; VISUAL DISORDER; VOMITING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; FEMALE; FRANCE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; POLYETHYLENE GLYCOLS; REGISTRIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; TELANGIECTASIS; VARICOSE VEINS;

EID: 77952896640     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01407.x     Document Type: Review

References (16)

1. Goldman MP, Bergan JJ, Guex JJ. Complications and adverse sequelae of sclerotherapy. In : Goldman MP, Bergan JJ, Guex J-J, editors. Sclerotherapy. Treatment of Varicose and Telangiectatic Leg Veins. 4th ed.
2. Conrad P, Malouf GM, Stacey MC. The Australian polidocanol (aethoxysklerol) study. Results at 2 years. Dermatol Surg 1995 21 : 334 336.
3. Conard J, Horellou MH, Elalamy I, Samama MM. Thromboses veineuses apres sclerotherapie; enquete clinico-biologique à propos de 42 observations. J Mal Vasc 1999 24 (Suppl A) : 97.
4. Varcoe PF. Ultrasound guided sclerotherapy: efficacy, adverse events and dosing - an international survey. Aust N Z J Phlebol 2003 7 : 17 24.
5. Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg 2007 26 : 22 8.
6. Guex J-J. Complications of Sclerotherapy: An Update. Dermatol Surg 2010 36 : 1056 1063.
7. Guex J-J, Allaert F-A, Gillet J-L, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005 31 : 123 128.
8. Jia X, Mowatt G, Burr JM, et al. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007 94 : 925 936.
9. Rabe E, Pannier F, Gerlach H, et al. Sclerotherapy of varicose veins Guideline of the German Society of Phlebology. Phlébologie 2008 61 : 43 51.
10. Gillet JL, Perrin MR, Allaert FA. Short-term and mid-term outcome of isolated symptomatic muscular calf vein thrombosis. J Vasc Surg 2007 46 : 513 519.
11. Hirsh J, Guyatt G, Albers GW, et al. Antithrombotic and thrombolytic therapy: American College of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 2008 133 (6 Suppl) : 110S 2S.
12. Ceulen RPM, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008 358 : 1525 1526.
13. Gillet JL, Guedes JM, Guex JJ, et al. Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009 24 : 131 138.
14. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006 43 : 162 164.
15. Gillet JL, Donnet A, Lausecker M, et al. Pathophysiology of visual disturbances occurring after foam sclerotherapy. Phlebology 2010 (in press).
16. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008 35 : 238 245.